Boston Scientific Corp. has announced it has received FDA approval and market launch of its Epic vascular self-expanding stent system, according to a news release.
Boston Scientific said the Epic stent is designed to open blocked arteries in patients with iliac artery stenosis. It is a self-expanding Nitinol stent designed to sustain vessel patency, while providing enhanced visibility and accuracy during placement.
"The Epic stent is another example of our commitment to innovation in treating peripheral vascular disease, a growing worldwide health concern," said Jeff Mirviss, president of the Boston Scientific peripheral interventions division, in the release. "This next-generation stent expands our growing peripheral interventions portfolio, complementing the leading Express LD balloon-expandable iliac stent, and offering physicians a versatile new option to treat patients with challenging lesions in the iliac arteries."
The Epic stent system received CE Mark approval and was launched in Europe and other international markets in 2009.
Related Articles on FDA Approvals:
Covalon Receives FDA Approval for Antimicrobial Silicone Adhesive Film
U-Systems Receives FDA Premarket Approval Letter for somo*v Automated Breast Ultrasound System
MAQUET Cardiovascular Receives FDA 510(k) Clearance for New Intra-Aortic Balloon Catheter Sizes